July 26, 2022 PSTC 15-year Anniversary Webinar Series Join scientists from PSTC member companies, health authorities and other key opinion leaders during the PSTC 15-year Anniversary W
July 25, 2022 Diary for Irritable Bowel Syndrome Symptoms-Constipation Now Available for Licensing C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) i
July 19, 2022 Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures
July 15, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impair
July 14, 2022 C-Path’s Dr. Amanda Klein Promoted to Transplant Therapeutic Consortium Executive Director TUCSON, Ariz., July 14, 2022 — Critical Path Institute (C-Path) has named Amanda Klein, Pharm.D., as Executive Director for its
June 30, 2022 Sample Size Calculator for a Surrogate Endpoint in Kidney Transplant Clinical Trials When: Thursday, June 30, 10 a.m. – 12 p.m. ET C-Path’s Transplant Therapeutics Consortium (TTC) invites you to jo
June 30, 2022 Diamyd Medical Joins International Consortium in Type 1 Diabetes TUCSON, Ariz., June 30, 2022 — Diamyd Medical will be a full voting member of the Type 1 Diabetes Consortium (T1DC) led by the U
June 29, 2022 C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, a
June 28, 2022 C-Path Welcomes RWS C-Path is proud to welcome RWS as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri